Class Action Securities Fraud Case Opens Against Paysafe Limited

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Schall Law Firm sues Paysafe Limited for securities fraud, alleging false statements about merchant risk exposure and understated credit losses between March-November 2025.

Class Action Securities Fraud Case Opens Against Paysafe Limited

The Schall Law Firm has initiated a securities fraud class action lawsuit against Paysafe Limited (PSFE), seeking investors who purchased company securities during an eight-month period to participate in the litigation. The firm alleges that Paysafe made materially false and misleading statements to investors regarding its exposure to high-risk clientele and failed to accurately disclose the composition of its merchant base.

According to the complaint, Paysafe allegedly understated its credit loss reserves while concealing higher-risk merchant category codes within its portfolio. These omissions are claimed to have misrepresented the company's financial health and risk profile to the investing public. The securities in question were purchased between March 4, 2025 and November 12, 2025.

Investors who experienced losses from PSFE securities during the specified timeframe have been invited to join the class action by contacting the law firm. The deadline for participation in this litigation is April 7, 2026. Class action representation in securities fraud cases allows affected shareholders to consolidate claims and share litigation costs while pursuing damages.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 20

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON